One morning last spring, about 200 senior citizens descended on the Coolidge Corner Theatre for a special program of classic old movies.
It was the first in a four-part series - the second one is today - called "Meet Me at the Coolidge...and make memories," designed to remind the audience of the good old days of cinema. Attendees got big welcomes and free popcorn and soda. They watched clips from "Oklahoma", "Casablanca," and "The Wizard of Oz", and saw legendary stars like Judy Garland, Katherine Hepburn, and Humphrey Bogart.
Right now, more than five million Americans have Alzheimer's disease, a number that is only expected to increase in the years ahead. I know the pain that Alzheimer's disease can cause - for those diagnosed with it, and for their families and caregivers - which is why my Administration is committed to finding a cure.
Bringing together two esteemed institutions known for groundbreaking Alzheimer's research, Cure Alzheimer's Fund has awarded the University of Pittsburgh a $300,00 grant and Massachusetts General Hospital/Harvard (MGH) a $100,000 grant to fund an innovative joint research project on Alzheimer's disease, which currently affects 5.3 billion Americans and their families.
Back in the 1980s, it was becoming evident that Alzheimer's disease was an imposing challenge whose weight on health and society was just beginning to be felt. As people began to live longer and the U.S. population began to age, more and more people were finding themselves on the receiving end of a diagnosis of this slow but deadly neurodegenerative disease.
The vaulted protection that intellectually active adults get from Alzheimer's disease has a dark downside, a study released Wednesday has found. Once dementia symptoms become evident and Alzheimer's disease is diagnosed in such patients, their mental decline can come with frightening speed.
In a year when news about Alzheimer's disease seems to whipsaw between encouraging and disheartening, a new discovery by an 84-year-old scientist has illuminated a new direction.
The scientist, Paul Greengard, who was awarded a Nobel Prize in 2000 for his work on signaling in brain cells, still works in his Rockefellar University lab in New York City seven days a week, walking there from his apartment two blocks away, taking his aging Bernese mountain dog, Alpha.
Researchers report that a spinal fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer's disease.
Although there has been increasing evidence of the value of this and other tests in finding signs of Alzheimer’s, the study, which will appear Tuesday in the Archives of Neurology, shows how accurate they can be. The new result is one of a number of remarkable recent findings about Alzheimer’s.
Two of the most common and dreaded illnesses in America may share a connection, with new research suggesting that having insulin resistance or type 2 diabetes raises your risk of developing the brain plaques associated with Alzheimer's disease.
After adjusting for other risk factors, the Japanese study found that people with the highest levels of fasting insulin had nearly six times the odds of having plaque deposits between nerves in the brain, compared to people with the lowest levels of fasting insulin.